·   Log in

Archive for December 4th, 2009

Serum to launch late phase human trials on inhalable measles vaccine in India

Friday, December 4, 2009 21:58

Serum Institute of India, the leading vaccine maker from the country, will carry out phase 2 and phase 3 human trials to test the efficacy of an investigational dry powder measles vaccines which is administered through inhalation.

This was posted under category: Clinical Trials, Featured  |  Read Full Story  |  1 Comment

HIV drug fosamprenavir (Lexiva) raises cholesterol; could lead to heart disease

Friday, December 4, 2009 19:44

The anti-HIV drug fosamprenavir calcium (Lexiva) could lead to heart disease, warns the maker of the drug GlaxoSmithKline.

This was posted under category: health  |  Read Full Story  |  0 Comments

Merck’s anti-fungal caspofungin (Cancidas) to carry warning on liver problems in kids

Friday, December 4, 2009 18:58

Caspofungin, an anti-fungal drug sold in the brand name Cancidas by Merck, can cause serious liver problems in children, warned US FDA.

This was posted under category: health  |  Read Full Story  |  0 Comments
Tagged with: , ,

TSO3 Sterizone appoved to sterilize endoscopes by US FDA

Friday, December 4, 2009 18:04

TSO3 Sterizone, a low temperature sterilization device for metal and heat sensitive instruments by TSO3, has approved to expand its use for endoscopes as well, by US FDA.

This was posted under category: medical devices  |  Read Full Story  |  1 Comment
Tagged with: ,

Weight-loss pill sibutramine (Meridia) may face ban in US

Friday, December 4, 2009 9:10

Weight loss drug sibutramine, which is being sold under the brand name Meridia by Abbott, could face ban in US.

This was posted under category: health  |  Read Full Story  |  0 Comments
Tagged with: , ,